A Stretchable, Transparent, Photothermally Stimulated Laser-Induced Graphene Patch for Noninvasive Skin Tumor Treatment.

A Stretchable, Transparent, Photothermally Stimulated Laser-Induced Graphene Patch for Noninvasive Skin Tumor Treatment.

Publication date: Mar 05, 2026

Melanoma causes over 80% of skin cancer-related deaths, with conventional therapies hampered by its aggressiveness, metastasis, and drug resistance. Noninvasive, biocompatible strategies are promising for next-generation cancer treatments. Herein, we developed a soft, stretchable laser-induced graphene (LIG)-Cu/PDMS patch, consisting of CuO-embedded LIG (active component) and biocompatible PDMS (flexible matrix). Chemically inert and breathable, the patch minimizes toxic side effects. Upon photothermal activation, it releases Cu that accumulates in melanoma tissue. In a mouse model, two 1-h phototherapy sessions achieved effective tumor suppression within 10 days. Mechanistically, the patch enhances reactive oxygen species production, inducing apoptosis, cuproptosis, and ferroptosis. It also inhibits tumor invasion/metastasis and boosts antitumor immunity, with stable performance enabling multiple uses (energy-efficient and environmentally sustainable). This work demonstrates graphene-based materials’ potential in cancer therapy via synergistic activation of multiple cell death pathways and efficacy in low-temperature phototherapy, expanding graphene’s application in malignant tumor treatment and highlighting its clinical translation prospects.

Open Access PDF

Concepts Keywords
Cancer cuproptosis
Drug ferroptosis
Efficient laser-induced graphene (LIG)
Laser low-temperature phototherapy
Phototherapy melanoma

Semantics

Type Source Name
disease MESH hyperthermia
disease MESH hypersensitivity
disease MESH infection
disease MESH recurrence
disease MESH resection margins
disease MESH death
drug DRUGBANK Oxygen
drug DRUGBANK (S)-Des-Me-Ampa
pathway REACTOME Translation
pathway KEGG Ferroptosis
pathway REACTOME Apoptosis
disease MESH metastasis
disease MESH skin cancer
pathway KEGG Melanoma
disease MESH Melanoma
disease MESH Tumor
drug DRUGBANK Activated charcoal
drug DRUGBANK Water
drug DRUGBANK Copper
pathway REACTOME Release
drug DRUGBANK Nitrogen
drug DRUGBANK Albendazole
disease MESH strain
drug DRUGBANK Propidium
drug DRUGBANK Iodide
pathway REACTOME Cell Cycle
disease MESH body weight
disease MESH weight loss
disease MESH fibrosis
drug DRUGBANK Calcium
drug DRUGBANK Glutathione
disease MESH GSH
pathway REACTOME Autophagy
pathway REACTOME Pyroptosis
drug DRUGBANK Iron
pathway REACTOME Signal Transduction
disease MESH inflammation
drug DRUGBANK Lipoic Acid
drug DRUGBANK Hydrogen peroxide
disease MESH hypoxia
drug DRUGBANK Glutathione disulfide
drug DRUGBANK ATP
disease MESH mitochondrial dysfunction
drug DRUGBANK Tretamine
disease MESH included
disease MESH rupture
disease MESH shock
disease MESH TTM
pathway REACTOME Metabolism
drug DRUGBANK ANX-510
pathway KEGG Lysosome
pathway KEGG Chemokine signaling pathway
disease MESH ICD
drug DRUGBANK Cycloserine
disease MESH DCs
pathway REACTOME Immune System
disease MESH necrosis
disease MESH edema
drug DRUGBANK Alkaline Phosphatase
disease MESH ALP
drug DRUGBANK Cholesterol
disease MESH scarring
drug DRUGBANK Aspartame
disease MESH PBS
disease MESH image
disease MESH Rad
disease MESH APC
drug DRUGBANK Acetate ion
drug DRUGBANK Medical air
drug DRUGBANK Fluorescein
drug DRUGBANK Coenzyme M
disease MESH Chai
disease MESH measles
pathway KEGG Measles
disease MESH carcinoma
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Carbon monoxide
drug DRUGBANK Silver
drug DRUGBANK Prussian blue
drug DRUGBANK Dextrose unspecified form
disease MESH Park
drug DRUGBANK Guanosine
disease MESH adenocarcinoma
drug DRUGBANK Mecasermin
disease MESH pancreatic cancer
pathway KEGG Pancreatic cancer
disease MESH uveal melanoma
disease MESH Dis
drug DRUGBANK Methylergometrine
pathway KEGG Hippo signaling pathway
pathway REACTOME Glycolysis
disease MESH Oncogenesis
disease MESH FSP1
disease MESH lung cancers
disease MESH ependymomas
disease MESH ovarian cancer
drug DRUGBANK Troleandomycin
disease MESH colorectal cancer
pathway KEGG Colorectal cancer
drug DRUGBANK Nonoxynol-9

Original Article

(Visited 17 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *